COPD Drugs Market
1 Study Coverage
1.1 COPD Drugs Revenue in COPD Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global COPD Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global COPD Drugs Market Size for the Year 2017-2028
1.2.2 Global COPD Drugs Market Size for the Year 2017-2028
1.3 COPD Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States COPD Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of COPD Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 COPD Drugs Market Dynamics
1.4.1 COPD Drugs Industry Trends
1.4.2 COPD Drugs Market Drivers
1.4.3 COPD Drugs Market Challenges
1.4.4 COPD Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 COPD Drugs by Type
2.1 COPD Drugs Market Segment by Type
2.1.1 Bronchodilators
2.1.2 PDE-4 Inhibitors
2.1.3 Steroids
2.1.4 Combination Therapies
2.1.5 Others
2.2 Global COPD Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global COPD Drugs Market Size by Type (2017-2028)
2.4 United States COPD Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States COPD Drugs Market Size by Type (2017-2028)
3 COPD Drugs by Application
3.1 COPD Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global COPD Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global COPD Drugs Market Size by Application (2017-2028)
3.4 United States COPD Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States COPD Drugs Market Size by Application (2017-2028)
4 Global COPD Drugs Competitor Landscape by Company
4.1 Global COPD Drugs Market Size by Company
4.1.1 Top Global COPD Drugs Companies Ranked by Revenue (2021)
4.1.2 Global COPD Drugs Revenue by Player (2017-2022)
4.2 Global COPD Drugs Concentration Ratio (CR)
4.2.1 COPD Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of COPD Drugs in 2021
4.2.3 Global COPD Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global COPD Drugs Headquarters, Revenue in COPD Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global COPD Drugs Headquarters and Area Served
4.3.2 Global COPD Drugs Companies Revenue in COPD Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into COPD Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States COPD Drugs Market Size by Company
4.5.1 Top COPD Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States COPD Drugs Revenue by Players (2020, 2021 & 2022)
5 Global COPD Drugs Market Size by Region
5.1 Global COPD Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global COPD Drugs Market Size by Region (2017-2028)
5.2.1 Global COPD Drugs Market Size by Region: 2017-2022
5.2.2 Global COPD Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America COPD Drugs Market Size YoY Growth 2017-2028
6.1.2 North America COPD Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific COPD Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific COPD Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe COPD Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe COPD Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America COPD Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America COPD Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa COPD Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa COPD Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Details
7.1.2 Pfizer Business Overview
7.1.3 Pfizer COPD Drugs Introduction
7.1.4 Pfizer Revenue in COPD Drugs Business (2017-2022)
7.1.5 Pfizer Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis COPD Drugs Introduction
7.2.4 Novartis Revenue in COPD Drugs Business (2017-2022)
7.2.5 Novartis Recent Development
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Details
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline COPD Drugs Introduction
7.3.4 GlaxoSmithKline Revenue in COPD Drugs Business (2017-2022)
7.3.5 GlaxoSmithKline Recent Development
7.4 Merck
7.4.1 Merck Company Details
7.4.2 Merck Business Overview
7.4.3 Merck COPD Drugs Introduction
7.4.4 Merck Revenue in COPD Drugs Business (2017-2022)
7.4.5 Merck Recent Development
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Company Details
7.5.2 Abbott Laboratories Business Overview
7.5.3 Abbott Laboratories COPD Drugs Introduction
7.5.4 Abbott Laboratories Revenue in COPD Drugs Business (2017-2022)
7.5.5 Abbott Laboratories Recent Development
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Details
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim COPD Drugs Introduction
7.6.4 Boehringer Ingelheim Revenue in COPD Drugs Business (2017-2022)
7.6.5 Boehringer Ingelheim Recent Development
7.7 AstraZeneca
7.7.1 AstraZeneca Company Details
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca COPD Drugs Introduction
7.7.4 AstraZeneca Revenue in COPD Drugs Business (2017-2022)
7.7.5 AstraZeneca Recent Development
7.8 Roche Holding AG
7.8.1 Roche Holding AG Company Details
7.8.2 Roche Holding AG Business Overview
7.8.3 Roche Holding AG COPD Drugs Introduction
7.8.4 Roche Holding AG Revenue in COPD Drugs Business (2017-2022)
7.8.5 Roche Holding AG Recent Development
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Company Details
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries COPD Drugs Introduction
7.9.4 Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2017-2022)
7.9.5 Teva Pharmaceutical Industries Recent Development
7.10 Vectura Group
7.10.1 Vectura Group Company Details
7.10.2 Vectura Group Business Overview
7.10.3 Vectura Group COPD Drugs Introduction
7.10.4 Vectura Group Revenue in COPD Drugs Business (2017-2022)
7.10.5 Vectura Group Recent Development
7.11 Mylan NV
7.11.1 Mylan NV Company Details
7.11.2 Mylan NV Business Overview
7.11.3 Mylan NV COPD Drugs Introduction
7.11.4 Mylan NV Revenue in COPD Drugs Business (2017-2022)
7.11.5 Mylan NV Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. COPD Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. COPD Drugs Market Trends
Table 3. COPD Drugs Market Drivers
Table 4. COPD Drugs Market Challenges
Table 5. COPD Drugs Market Restraints
Table 6. Global COPD Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States COPD Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global COPD Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States COPD Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top COPD Drugs Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global COPD Drugs Revenue by Player, (US$ Million), 2017-2022
Table 12. Global COPD Drugs Revenue Share by Player, 2017-2022
Table 13. Global COPD Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global COPD Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Drugs as of 2021)
Table 15. Top Players of COPD Drugs in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in COPD Drugs Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into COPD Drugs Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top COPD Drugs Players in United States Market, Ranking by Revenue (2021)
Table 20. United States COPD Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States COPD Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global COPD Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global COPD Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global COPD Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America COPD Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific COPD Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe COPD Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa COPD Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa COPD Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Pfizer Company Details
Table 31. Pfizer Business Overview
Table 32. Pfizer COPD Drugs Product
Table 33. Pfizer Revenue in COPD Drugs Business (2017-2022) & (US$ Million)
Table 34. Pfizer Recent Development
Table 35. Novartis Company Details
Table 36. Novartis Business Overview
Table 37. Novartis COPD Drugs Product
Table 38. Novartis Revenue in COPD Drugs Business (2017-2022) & (US$ Million)
Table 39. Novartis Recent Development
Table 40. GlaxoSmithKline Company Details
Table 41. GlaxoSmithKline Business Overview
Table 42. GlaxoSmithKline COPD Drugs Product
Table 43. GlaxoSmithKline Revenue in COPD Drugs Business (2017-2022) & (US$ Million)
Table 44. GlaxoSmithKline Recent Development
Table 45. Merck Company Details
Table 46. Merck Business Overview
Table 47. Merck COPD Drugs Product
Table 48. Merck Revenue in COPD Drugs Business (2017-2022) & (US$ Million)
Table 49. Merck Recent Development
Table 50. Abbott Laboratories Company Details
Table 51. Abbott Laboratories Business Overview
Table 52. Abbott Laboratories COPD Drugs Product
Table 53. Abbott Laboratories Revenue in COPD Drugs Business (2017-2022) & (US$ Million)
Table 54. Abbott Laboratories Recent Development
Table 55. Boehringer Ingelheim Company Details
Table 56. Boehringer Ingelheim Business Overview
Table 57. Boehringer Ingelheim COPD Drugs Product
Table 58. Boehringer Ingelheim Revenue in COPD Drugs Business (2017-2022) & (US$ Million)
Table 59. Boehringer Ingelheim Recent Development
Table 60. AstraZeneca Company Details
Table 61. AstraZeneca Business Overview
Table 62. AstraZeneca COPD Drugs Product
Table 63. AstraZeneca Revenue in COPD Drugs Business (2017-2022) & (US$ Million)
Table 64. AstraZeneca Recent Development
Table 65. Roche Holding AG Company Details
Table 66. Roche Holding AG Business Overview
Table 67. Roche Holding AG COPD Drugs Product
Table 68. Roche Holding AG Revenue in COPD Drugs Business (2017-2022) & (US$ Million)
Table 69. Roche Holding AG Recent Development
Table 70. Teva Pharmaceutical Industries Company Details
Table 71. Teva Pharmaceutical Industries Business Overview
Table 72. Teva Pharmaceutical Industries COPD Drugs Product
Table 73. Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2017-2022) & (US$ Million)
Table 74. Teva Pharmaceutical Industries Recent Development
Table 75. Vectura Group Company Details
Table 76. Vectura Group Business Overview
Table 77. Vectura Group COPD Drugs Product
Table 78. Vectura Group Revenue in COPD Drugs Business (2017-2022) & (US$ Million)
Table 79. Vectura Group Recent Development
Table 80. Mylan NV Company Details
Table 81. Mylan NV Business Overview
Table 82. Mylan NV COPD Drugs Product
Table 83. Mylan NV Revenue in COPD Drugs Business (2017-2022) & (US$ Million)
Table 84. Mylan NV Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. COPD Drugs Product Picture
Figure 2. Global COPD Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global COPD Drugs Market Size 2017-2028 (US$ Million)
Figure 4. United States COPD Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States COPD Drugs Market Size 2017-2028 (US$ Million)
Figure 6. United States COPD Drugs Market Share in Global 2017-2028
Figure 7. COPD Drugs Report Years Considered
Figure 8. Product Picture of Bronchodilators
Figure 9. Product Picture of PDE-4 Inhibitors
Figure 10. Product Picture of Steroids
Figure 11. Product Picture of Combination Therapies
Figure 12. Product Picture of Others
Figure 13. Global COPD Drugs Market Share by Type in 2022 & 2028
Figure 14. Global COPD Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 15. Global COPD Drugs Market Share by Type (2017-2028)
Figure 16. United States COPD Drugs Market Share by Type in 2022 & 2028
Figure 17. United States COPD Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 18. United States COPD Drugs Market Share by Type (2017-2028)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Clinics
Figure 21. Product Picture of Others
Figure 22. Global COPD Drugs Market Share by Application in 2022 & 2028
Figure 23. Global COPD Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global COPD Drugs Market Share by Application (2017-2028)
Figure 25. United States COPD Drugs Market Share by Application in 2022 & 2028
Figure 26. United States COPD Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States COPD Drugs Market Share by Application (2017-2028)
Figure 28. North America COPD Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe COPD Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific COPD Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America COPD Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa COPD Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. UAE COPD Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in COPD Drugs Business (2017-2022)
Figure 57. Novartis Revenue Growth Rate in COPD Drugs Business (2017-2022)
Figure 58. GlaxoSmithKline Revenue Growth Rate in COPD Drugs Business (2017-2022)
Figure 59. Merck Revenue Growth Rate in COPD Drugs Business (2017-2022)
Figure 60. Abbott Laboratories Revenue Growth Rate in COPD Drugs Business (2017-2022)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in COPD Drugs Business (2017-2022)
Figure 62. AstraZeneca Revenue Growth Rate in COPD Drugs Business (2017-2022)
Figure 63. Roche Holding AG Revenue Growth Rate in COPD Drugs Business (2017-2022)
Figure 64. Teva Pharmaceutical Industries Revenue Growth Rate in COPD Drugs Business (2017-2022)
Figure 65. Vectura Group Revenue Growth Rate in COPD Drugs Business (2017-2022)
Figure 66. Mylan NV Revenue Growth Rate in COPD Drugs Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Industry Market Size
